Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2016

01-11-2016 | Original Research

Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System

Authors: Shivan J. Mehta, MD MBA MSHP, Christopher D. Jensen, PhD MPH, Virginia P. Quinn, PhD MPH, Joanne E. Schottinger, MD, Ann G. Zauber, PhD, Reinier Meester, MS, Adeyinka O. Laiyemo, MD MPH, Stacey Fedewa, MPH, Michael Goodman, MD MPH, Robert H. Fletcher, MD MSc, Theodore R. Levin, MD, Douglas A. Corley, MD PhD, Chyke A. Doubeni, MD MPH

Published in: Journal of General Internal Medicine | Issue 11/2016

Login to get access

Abstract

Background

Screening outreach programs using population health management principles offer services uniformly to all eligible persons, but racial/ethnic colorectal cancer (CRC) screening patterns in such programs are not well known.

Objective

To examine the association between race/ethnicity and the receipt of CRC screening and timely follow-up of positive results before and after implementation of a screening program.

Design

Retrospective cohort study of screen-eligible individuals at the Kaiser Permanente Northern California community-based integrated healthcare delivery system (2004–2013).

Subjects

A total of 868,934 screen-eligible individuals 51–74 years of age at cohort entry, which included 662,872 persons in the period before program implementation (2004–2006), 654,633 during the first 3 years after implementation (2007–2009), and 665,268 in the period from 4 to 7 years (2010–2013) after program implementation.

Intervention

A comprehensive system-wide long-term effort to increase CRC that included leadership alignment, goal-setting, and quality assurance through a PHM approach, using mailed fecal immunochemical testing (FIT) along with offering screening at office visits.

Main Measures

Differences over time and by race/ethnicity in up-to-date CRC screening (overall and by test type) and timely follow-up of a positive screen. Race/ethnicity categories included non-Hispanic white, non-Hispanic black, Hispanic/Latino, Asian/Pacific Islander, Native American, and multiple races.

Key Results

From 2004 to 2013, age/sex-adjusted CRC screening rates increased in all groups, including 35.2 to 81.1 % among whites and 35.6 to 78.0 % among blacks. Screening rates among Hispanics (33.1 to 78.3 %) and Native Americans (29.4 to 74.5 %) remained lower than those for whites both before and after program implementation. Blacks, who had slightly higher rates before program implementation (adjusted rate ratio [RR] = 1.04, 99 % CI: 1.02–1.05), had lower rates after program implementation (RR for period from 4 to 7 years = 0.97, 99 % CI: 0.96–0.97). There were also substantial improvements in timely follow-up of positive screening results.

Conclusions

In this screening program using core PHM principles, CRC screening increased markedly in all racial/ethnic groups, but disparities persisted for some groups and developed in others, which correlated with levels of adoption of mailed FIT.
Appendix
Available only for authorised users
Literature
1.
go back to reference Doubeni CA, Corley DA, Zauber AG. Colorectal cancer health disparities and the role of US law and health policy. Gastroenterology. 2016;150(5):1052–5.CrossRefPubMed Doubeni CA, Corley DA, Zauber AG. Colorectal cancer health disparities and the role of US law and health policy. Gastroenterology. 2016;150(5):1052–5.CrossRefPubMed
2.
go back to reference Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9.CrossRefPubMed
3.
go back to reference Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33.CrossRefPubMed Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet. 2010;375(9726):1624–33.CrossRefPubMed
4.
go back to reference Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57.CrossRefPubMedPubMedCentral Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345–57.CrossRefPubMedPubMedCentral
5.
go back to reference Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case–control study. Ann Intern Med. 2013;158(5 Pt 1):312–20.CrossRefPubMedPubMedCentral Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case–control study. Ann Intern Med. 2013;158(5 Pt 1):312–20.CrossRefPubMedPubMedCentral
6.
go back to reference Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–105.CrossRefPubMed Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013;369(12):1095–105.CrossRefPubMed
7.
go back to reference U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.
8.
go back to reference Fedewa SA, Goodman M, Flanders WD, Han X, Smith RA, Ward ME, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015;121(18):3272–80.CrossRefPubMed Fedewa SA, Goodman M, Flanders WD, Han X, Smith RA, Ward ME, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015;121(18):3272–80.CrossRefPubMed
10.
go back to reference Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015. Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, et al. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015.
11.
go back to reference Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(4):401–5.CrossRef Robbins AS, Siegel RL, Jemal A. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol Off J Am Soc Clin Oncol. 2012;30(4):401–5.CrossRef
12.
go back to reference Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health. 2010;100(10):1912–6.CrossRefPubMedPubMedCentral Soneji S, Iyer SS, Armstrong K, Asch DA. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health. 2010;100(10):1912–6.CrossRefPubMedPubMedCentral
13.
go back to reference Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.CrossRefPubMed Cooper GS, Koroukian SM. Racial disparities in the use of and indications for colorectal procedures in Medicare beneficiaries. Cancer. 2004;100(2):418–24.CrossRefPubMed
14.
go back to reference Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomark Prev. 2009;18(8):2170–5.CrossRef Doubeni CA, Laiyemo AO, Reed G, Field TS, Fletcher RH. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomark Prev. 2009;18(8):2170–5.CrossRef
15.
go back to reference Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102(8):538–46.CrossRefPubMedPubMedCentral Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, et al. Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst. 2010;102(8):538–46.CrossRefPubMedPubMedCentral
16.
go back to reference Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562–71.CrossRefPubMedPubMedCentral Samuel CA, Landrum MB, McNeil BJ, Bozeman SR, Williams CD, Keating NL. Racial disparities in cancer care in the Veterans Affairs health care system and the role of site of care. Am J Public Health. 2014;104(Suppl 4):S562–71.CrossRefPubMedPubMedCentral
17.
go back to reference Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.CrossRefPubMed Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104–17.CrossRefPubMed
18.
go back to reference Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Available at: http://seer.cancer.gov/csr/1975_2013/. Accessed 14 June 2016. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, based on November 2015 SEER data submission, posted to the SEER web site, April 2016. Available at: http://​seer.​cancer.​gov/​csr/​1975_​2013/​.​ Accessed 14 June 2016.
19.
go back to reference Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313–9.CrossRefPubMed Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313–9.CrossRefPubMed
20.
go back to reference Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–9.CrossRefPubMed Wee CC, McCarthy EP, Phillips RS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med. 2005;41(1):23–9.CrossRefPubMed
21.
go back to reference Stimpson JP, Pagan JA, Chen LW. Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood). 2012;31(12):2747–54.CrossRef Stimpson JP, Pagan JA, Chen LW. Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood). 2012;31(12):2747–54.CrossRef
22.
go back to reference Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46(3):228–36.CrossRefPubMed Liss DT, Baker DW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med. 2014;46(3):228–36.CrossRefPubMed
23.
go back to reference Soneji S, Armstrong K, Asch DA. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract. 2012;8(5):e125–34.CrossRefPubMedPubMedCentral Soneji S, Armstrong K, Asch DA. Socioeconomic and physician supply determinants of racial disparities in colorectal cancer screening. J Oncol Pract. 2012;8(5):e125–34.CrossRefPubMedPubMedCentral
24.
go back to reference Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101–10.CrossRefPubMed Levin TR, Jamieson L, Burley DA, Reyes J, Oehrli M, Caldwell C. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011;33(1):101–10.CrossRefPubMed
25.
go back to reference Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(5 Suppl):1201–13.CrossRefPubMed Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(5 Suppl):1201–13.CrossRefPubMed
26.
go back to reference Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer. 2003;39(12):1648–53.CrossRefPubMed Madlensky L, Goel V, Polzer J, Ashbury FD. Assessing the evidence for organised cancer screening programmes. Eur J Cancer. 2003;39(12):1648–53.CrossRefPubMed
27.
go back to reference Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.CrossRefPubMed Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98(9):2082–91.CrossRefPubMed
28.
go back to reference Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854–60.CrossRefPubMedPubMedCentral Rhoads KF, Patel MI, Ma Y, Schmidt LA. How do integrated health care systems address racial and ethnic disparities in colon cancer? J Clin Oncol. 2015;33(8):854–60.CrossRefPubMedPubMedCentral
29.
go back to reference von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40(3):712–8.CrossRef von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40(3):712–8.CrossRef
30.
go back to reference Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomark Prev. 2014;23(7):1147–58.CrossRef Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, et al. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomark Prev. 2014;23(7):1147–58.CrossRef
31.
go back to reference Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109(3):612–20.CrossRefPubMed Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007;109(3):612–20.CrossRefPubMed
32.
go back to reference Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract. 1997;11(1):5–12.PubMed Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract. 1997;11(1):5–12.PubMed
33.
go back to reference Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.CrossRefPubMed Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int J Cancer. 2008;122(6):1357–67.CrossRefPubMed
36.
go back to reference van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409–15.CrossRefPubMed van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, et al. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut. 2013;62(3):409–15.CrossRefPubMed
37.
go back to reference Partin MR, Powell AA, Nugent S, Ordin DL. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals. J Healthc Qual. 2013;35(3):41–8.CrossRefPubMed Partin MR, Powell AA, Nugent S, Ordin DL. Colorectal cancer diagnosis improvement project evaluation demonstrates the importance of using multiple measures to track progress toward timeliness goals. J Healthc Qual. 2013;35(3):41–8.CrossRefPubMed
38.
go back to reference Partin MR, Burgess DJ, Burgess JF Jr, Gravely A, Haggstrom D, Lillie SE, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomark Prev. 2015;24(2):422–34.CrossRef Partin MR, Burgess DJ, Burgess JF Jr, Gravely A, Haggstrom D, Lillie SE, et al. Organizational predictors of colonoscopy follow-up for positive fecal occult blood test results: an observational study. Cancer Epidemiol Biomark Prev. 2015;24(2):422–34.CrossRef
39.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed
40.
go back to reference Doubeni CA, Jambaulikar GD, Fouayzi H, Robinson SB, Gunter MJ, Field TS, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population--a retrospective cohort study. PLoS ONE. 2012;7(5):e36392.CrossRefPubMedPubMedCentral Doubeni CA, Jambaulikar GD, Fouayzi H, Robinson SB, Gunter MJ, Field TS, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population--a retrospective cohort study. PLoS ONE. 2012;7(5):e36392.CrossRefPubMedPubMedCentral
41.
go back to reference Baker DW, Brown T, Buchanan DR, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41.CrossRefPubMed Baker DW, Brown T, Buchanan DR, et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1235–41.CrossRefPubMed
42.
43.
go back to reference Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63.CrossRefPubMedPubMedCentral Groeneveld PW, Sonnad SS, Lee AK, Asch DA, Shea JE. Racial differences in attitudes toward innovative medical technology. J Gen Intern Med. 2006;21(6):559–63.CrossRefPubMedPubMedCentral
44.
go back to reference Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRefPubMed Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24(2):211–7.CrossRefPubMed
45.
go back to reference Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906–12.CrossRefPubMed Lasser KE, Murillo J, Lisboa S, et al. Colorectal cancer screening among ethnically diverse, low-income patients: a randomized controlled trial. Arch Intern Med. 2011;171(10):906–12.CrossRefPubMed
46.
go back to reference Walsh JM, Salazar R, Nguyen TT, Kaplan C, Nguyen L, Hwang J, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.CrossRefPubMedPubMedCentral Walsh JM, Salazar R, Nguyen TT, Kaplan C, Nguyen L, Hwang J, et al. Healthy colon, healthy life: a novel colorectal cancer screening intervention. Am J Prev Med. 2010;39(1):1–14.CrossRefPubMedPubMedCentral
47.
go back to reference Doubeni CA. The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer. 2014;120(18):2810–3.CrossRefPubMed Doubeni CA. The impact of colorectal cancer screening on the US population: is it time to celebrate? Cancer. 2014;120(18):2810–3.CrossRefPubMed
Metadata
Title
Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System
Authors
Shivan J. Mehta, MD MBA MSHP
Christopher D. Jensen, PhD MPH
Virginia P. Quinn, PhD MPH
Joanne E. Schottinger, MD
Ann G. Zauber, PhD
Reinier Meester, MS
Adeyinka O. Laiyemo, MD MPH
Stacey Fedewa, MPH
Michael Goodman, MD MPH
Robert H. Fletcher, MD MSc
Theodore R. Levin, MD
Douglas A. Corley, MD PhD
Chyke A. Doubeni, MD MPH
Publication date
01-11-2016
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 11/2016
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3792-1

Other articles of this Issue 11/2016

Journal of General Internal Medicine 11/2016 Go to the issue

Letter to the Editor

Vitamin D: Ten Beliefs